UPS Healthcare has announced a collaboration with Dr. Reddy’s Laboratories to get 30 tonnes of temperature-sensitive pharmaceuticals from India to the United States via Europe.
Given the supply chain challenges and restrictions due to the Coronavirus pandemic, the two companies have created an emergency supply chain plan to replenish pharmaceutical stocks in U.S. markets. For this purpose, a flight originated in Hyderabad, India, moved through UPS’s European air hub in Cologne, Germany, and continued to the UPS Worldport air hub in Louisville, Kentucky.
“During this pandemic, moving critical controlled room temperature medicines requires extra planning given the air market capacity demand levels,” said Wes Wheeler, president of UPS Healthcare. “This collaboration enabled Dr. Reddy’s to replenish its stocks in U.S. locations and provide essential medicines to meet demand.”
Puvvala Yugandhar, head of global supply chain at Dr. Reddy’s Laboratories, said: “In this critical situation, we connected with the UPS Healthcare team who helped ensure that critical medicines reach pharmacies and hospitals in the U.S. on time for patients.”
The world's largest collection of global supply chain intelligence